Literature DB >> 29168825

Disease progression: Divergent paths.

Sarah DeWeerdt1.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 29168825     DOI: 10.1038/d41586-017-06925-2

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

Review 1.  Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges.

Authors:  Prarthana Thiagarajan; Guruprasad P Aithal
Journal:  J Clin Exp Hepatol       Date:  2019-03-13

2.  Statistical Physics for Medical Diagnostics: Learning, Inference, and Optimization Algorithms.

Authors:  Abolfazl Ramezanpour; Andrew L Beam; Jonathan H Chen; Alireza Mashaghi
Journal:  Diagnostics (Basel)       Date:  2020-11-19

Review 3.  p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.

Authors:  Jelena Krstic; Markus Galhuber; Tim J Schulz; Michael Schupp; Andreas Prokesch
Journal:  Int J Mol Sci       Date:  2018-03-20       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.